BioSpace News Archive

Business

MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab

MorphoSys AG announces that it has entered into a global collaboration and licensing agreement with Incyte Corporation to further develop and commercialize MorphoSys’ proprietary anti-CD19 antibody tafasitamab.

January 15, 2020
·
7 min read
Policy

FDA Advisory Committees Vote Against Approval of Nektar’s Opioid Painkiller

In a painful blow to the San Francisco-based company, the committees voted unanimously, 27 to 0, not to recommend approval.

January 15, 2020
·
2 min read
·
Mark Terry
The Digital Revolution: Digital Therapeutics, Drug Discovery and Beyond

It’s entirely possible that what is now being seen as a digital transformation in so many areas will in time merely become a standard set of tools used in all areas of the life sciences, from drug discovery and development, regulation and actual therapeutic devices.

January 15, 2020
·
8 min read
·
Mark Terry
Pharm Country

JPM Day 3: High Prices in San Francisco Are a Problem, Galapagos Strikes Fibrosis Deal

While the conditions surrounding the City by the Bay are in a negative light, there is still a significant amount of positive news coming out of the conference.

January 15, 2020
·
5 min read
·
Alex Keown
Drug Development

BioSpace Global Roundup, Jan. 16

Companies from across the globe provide updates to their business and pipeline.

January 15, 2020
·
7 min read
·
Alex Keown
sphingotec Launches IVD Test for Kidney Function Biomarker penKid(R) on Nexus IB10 POCT Platform

sphingotec launches a CE-marked point-of-care IVD assay for Proenkephalin (penKid(R)), the company’s proprietary biomarker for real-time assessment of kidney function in critical care settings

January 15, 2020
·
7 min read
Deals

Novo Seeds Provides Business Update

Novo Seeds, the early stage investment and company creation team of Novo Holdings, publishes its review of 2019 - a year of significant progress and growth.

January 15, 2020
·
3 min read
Deals

The Defense Health Program Department of Defense Peer Reviewed Medical Research Program Anticipated Funding Opportunities for Fiscal Year 2020 (FY20)

The FY20 Defense Appropriations Act provides funding to the Department of Defense Peer Reviewed Medical Research Program to support medical research projects of clear scientific merit and direct relevance to military health.

January 15, 2020
·
2 min read
Business

Accellix, Inc. Announces the Appointment of Nir Nimrodi as Chairman and Chief Executive Officer

Nimrodi Will Lead the Company’s Accelerated Growth as It Launches Custom and Standardized Panel Assays to Be Used by Its Expanding Installed Base.

January 15, 2020
·
2 min read
Biotech Beach

Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter

Biomerica announced a net loss for the three months ended November 30, 2019 of $485,260, or $0.05 per share, versus a net loss of $477,244, or $0.05 per share, in the previous fiscal year during the same quarter.

January 15, 2020
·
3 min read